BCIQ Profiles

Company Profile Report
0413 deals fn qts
BioCentury & Getty Images


April 13 Quick Takes: Mega-rounds for Flagship's Repertoire, Arcellx, GH, Theseus; plus Biophytis, Resilience, Cerevel, C4X, Sanofi and more

Apr 14, 2021 | 2:11 AM GMT

Immune medicines company Repertoire Immune Medicines Inc. raised $189 million in a series B financing from founding investor Flagship Pioneering and other investors including Softbank Vision Fund 2i, the Public Sector Pension Investment Board (PSP Investments), the Alaska Permanent Fund and Invus. Repertoire, which debuted in March 2020 after the December 2019 merger of two other Flagship companies, has raised more than $350 million.

Read the full 933 word article

How to gain access

Continue reading with a
two-week free trial.